EPINEPHRINE injection, solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

epinephrine injection, solution

american regent, inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine 1 mg in 1 ml - in general, the most common uses of epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity reactions to drugs and other allergens, and to prolong the action of infiltration anesthetics. its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes, but it is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock. epinephrine is used as a hemostatic agent. it is also used in treating mucosal congestion of hay fever, rhinitis and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. epinephrine injection can be utilized to prolong the action of local anesthetics (see c

ADEQUAN I.M.- polysulfated glycosaminoglycan injection, solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

adequan i.m.- polysulfated glycosaminoglycan injection, solution

american regent, inc. - polysulfated glycosaminoglycan (unii: 268aw7000t) (polysulfated glycosaminoglycan - unii:268aw7000t) - polysulfated glycosaminoglycan 100 mg in 1 ml - adequan® i.m. multi-dose is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. there are no known contraindications to the use of intramuscular polysulfated glycosaminoglycan.

EPINEPHRINE injection, solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

epinephrine injection, solution

american regent, inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - in general, the most common uses of epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity reactions to drugs and other allergens, and to prolong the action of infiltration anesthetics. its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes, but it is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock. epinephrine is used as a hemostatic agent. it is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. epinephrine injection can be utilized to prolong the action of intraspinal and local a

ADEQUAN I.M.- polysulfated glycosaminoglycan injection, solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

adequan i.m.- polysulfated glycosaminoglycan injection, solution

american regent, inc. - polysulfated glycosaminoglycan (unii: 268aw7000t) (polysulfated glycosaminoglycan - unii:268aw7000t) - adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. there are no known contraindications to the use of intramuscular polysulfated glycosaminoglycan.

ATROPINE SULFATE INJECTION, USP Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

atropine sulfate injection, usp

american regent, inc. - atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - atropine sulfate 1 mg in 1 ml - - in the treatment of parkinsonism. rigidity and tremor relieved by the apparently selective depressant action. - in the gastrointestinal tract to relieve pylorospasm, hypertonicity of the small intestine and the hypermotility of the colon. - to relieve hypertonicity of the uterine muscle. - to relax the spasm of biliary and uretered colic and bronchial spasm. - to diminish the tone of the detrusor muscle of the urinary bladder in the treatment of urinary tract disorders. - to control the crying and laughing episodes in patients with brain lesions. - in cases of closed head injuries which cause acetylcholine to be released or to be present in cerebrospinal fluid which in turn causes abnormal eeg patterns, stupor and neurological signs. - in the management of peptic ulcer. - in anesthesia to control excessive salivation and bronchial secretions. - to control rhinorrhea of acute rhinitis or hay fever. - as an antidote for pilocarpine, physostigmine, isoflurophate, choline esters, certain species of aminata and

LATANOPROST- latanoprost solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

latanoprost- latanoprost solution

american regent, inc. - latanoprost (unii: 6z5b6hvf6o) (latanoprost - unii:6z5b6hvf6o) - latanoprost 50 ug in 1 ml - latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredients in this product. teratogenic effects reproduction studies have been performed in rats and rabbits. in rabbits, an incidence of 4 of 16 dams had no viable fetuses at a dose that was approximately 80 times the maximum human dose, and the highest nonembryocidal dose in rabbits was approximately 15 times the maximum human dose. there are no adequate and well-controlled studies in pregnant women. latanoprost ophthalmic solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. it is not known whether this drug or its metabolites are excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when latanoprost ophthalmic solution is administered to a nursing woman. safety and effectiv

TRIMETHOBENZAMIDE HYDROCHLORIDE - trimethobenzamide hydrochloride injection, solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

trimethobenzamide hydrochloride - trimethobenzamide hydrochloride injection, solution

american regent, inc. - trimethobenzamide hydrochloride (unii: wdq5p1sx7q) (trimethobenzamide - unii:w2x096qy97) - trimethobenzamide hydrochloride injection is indicated for the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis. trimethobenzamide hydrochloride injection is contraindicated in pediatric patients and in patients with known hypersensitivity to trimethobenzamide.

CYANOCOBALAMIN injection, solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

cyanocobalamin injection, solution

american regent, inc. - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin 1000 ug in 1 ml - cyanocobalamin is indicated for vitamin b12 deficiencies due to malabsorption which may be associated with the following conditions: -  addisonian (pernicious) anemia -  gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy -  fish tapeworm infestation -  malignancy of pancreas or bowel -  folic acid deficiency it may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see drug interactions ), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue. such measures remove the need for long-term administration of cyanocobalamin. requirements of vitamin b12 in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be met with oral

CALCIUM CHLORIDE injection, solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

calcium chloride injection, solution

american regent, inc. - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - 10% calcium chloride injection is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels. calcium chloride is contraindicated for cardiac resuscitation in the presence of ventricular fibrillation or in patients with the risk of existing digitalis toxicity. calcium chloride is not recommended in the treatment of asystole and electromechanical dissociation. none known.

VASOPRESSIN injection, solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

vasopressin injection, solution

american regent, inc. - vasopressin (unii: y4907o6mfd) (vasopressin - unii:y4907o6mfd) - vasopressin injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. vasopressin injection 1 ml single-dose vial and 10 ml multiple-dose vial are contraindicated in patients with known allergy or hypersensitivity to 8-l-arginine vasopressin or chlorobutanol.  risk summary there are no available data on vasopressin injection use in pregnant women to inform a drug associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with vasopressin. clinical considerations dose adjustments during pregnancy and the postpartum period because of increased clearance of vasopressin in the second and third trimester, the dose of vasopressin injection may need to be increased [see dosage and administration (2.2) and clinical pharmacology (12.3)].  maternal adverse reactions vasopressin injection may produce tonic uterine contractions. vasopressin receptors are